BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28851249)

  • 1. Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP).
    Cuomo G; Brancaccio G; Stornaiuolo G; Manno D; Gaeta GL; Mussini C; Puoti M; Gaeta GB
    Infect Dis (Lond); 2018 Feb; 50(2):125-132. PubMed ID: 28851249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
    Merli M; Lucidi C; Di Gregorio V; Falcone M; Giannelli V; Lattanzi B; Giusto M; Ceccarelli G; Farcomeni A; Riggio O; Venditti M
    PLoS One; 2015; 10(5):e0127448. PubMed ID: 25996499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.
    Falcone M; Venditti M; Shindo Y; Kollef MH
    Int J Infect Dis; 2011 Aug; 15(8):e545-50. PubMed ID: 21616695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Bacterial Aetiology, Antibiotic Resistance and Treatment Outcomes: A Study From North India.
    Kumar S; Jan RA; Fomda BA; Rasool R; Koul P; Shah S; Khan UH; Qadri SM; Masoodi SR; Mantoo S; Muzamil M
    Lung; 2018 Aug; 196(4):469-479. PubMed ID: 29691645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease.
    Kuo MT; Yang SC; Lu LS; Hsu CN; Kuo YH; Kuo CH; Liang CM; Kuo CM; Wu CK; Tai WC; Chuah SK
    BMC Gastroenterol; 2015 May; 15():61. PubMed ID: 26268474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis.
    Manno D; Puoti M; Signorini L; Lapadula G; Cadeo B; Soavi L; Paraninfo G; Allegri R; Cristini G; Viale P; Carosi G
    Infection; 2009 Aug; 37(4):334-9. PubMed ID: 19629382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.
    Salerno F; Borzio M; Pedicino C; Simonetti R; Rossini A; Boccia S; Cacciola I; Burroughs AK; Manini MA; La Mura V; Angeli P; Bernardi M; Dalla Gasperina D; Dionigi E; Dibenedetto C; Arghittu M;
    Liver Int; 2017 Jan; 37(1):71-79. PubMed ID: 27364035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study.
    Falcone M; Corrao S; Licata G; Serra P; Venditti M
    Intern Emerg Med; 2012 Dec; 7(6):523-31. PubMed ID: 22688529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia.
    Kollef MH; Shorr A; Tabak YP; Gupta V; Liu LZ; Johannes RS
    Chest; 2005 Dec; 128(6):3854-62. PubMed ID: 16354854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP).
    Kaku N; Yanagihara K; Morinaga Y; Izumikawa K; Nagashima S; Kakeya H; Yamamoto Y; Fukuda M; Takatani H; Fukuda M; Hashiguchi K; Kohno S
    J Infect Chemother; 2013 Feb; 19(1):70-6. PubMed ID: 22850821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP).
    Fukuyama H; Yamashiro S; Tamaki H; Kishaba T
    J Infect Chemother; 2013 Aug; 19(4):719-26. PubMed ID: 23354936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of bacterial infections in patients with liver cirrhosis. Experience in a Spanish tertiary health center.
    Klímová K; Padilla C; Ávila JC; Clemente G; Ochoa A
    Biomedica; 2016 Mar; 36(1):121-32. PubMed ID: 27622445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
    Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
    Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial infections and hepatic encephalopathy in liver cirrhosis-prophylaxis and treatment.
    Piotrowski D; Boroń-Kaczmarska A
    Adv Med Sci; 2017 Sep; 62(2):345-356. PubMed ID: 28514703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.